Skip to contentG
Glucose Health, Inc.
G
GLUCGlucose Health, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$15.19K$15.19Kderived+826.2% vs Q4 2015 Net Income-$132.99K-$132.99KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Glucose Health, Inc. · CIK 1420108 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$386+601.8% Operating Incomederived-$24,848N/M Operating Cash Flowderived-$3,347N/M Margins · derivedGross margin2.5%−0.8 pt vs Q4 2015
Operating margin-163.6%+745.7 pt vs Q4 2015
Net margin-875.5%+1978.0 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 29, 2017 · 88 d after period end